About two decades ago, the capsular polysaccharide of Klebsiella pneumoniae (CPS-K) type 2 was reported to inhibit the multiplication of the pneumonitis virus of mice (11, 14) and mumps virus (10) . This antiviral activity was observed in mice and chicken embryos. This substance was found to exhibit the protective effect on pneumonia of mice, due to the pneumonitis virus of mice, even when administered after definite pneumonia had developed (11) . This finding probably constitutes the first demonstration of successful chemotherapy of an experimental viral disease (28) . Nevertheless, further studies to define the mechanism of action of CPS-K did not follow.
We have found that CPS-K isolated from the type 1 Kasuya strain exhibits a strong adjuvant effect on antibody responses to various antigens in mice, and its effect is much stronger than other known adjuvants, such as complete Freund adjuvant, Escherichia coli endotoxin (lipopolysaccharide [LPS] ), and zymosan (18, 19, (21) (22) (23) . Furthermore, it has been found that nonspecific stimulation of immunoglobulin synthesis can be induced in mice by injection of CPS-K (20) . The active substance responsible for both the strong adjuvanticity and the nonspecific stimulation of immunoglobulin synthesis has been characterized (19, 20) . At this stage of a series of studies on biological properties of CPS-K, we were interested in whether it might exhibit interferon-inducing activity in animals. This activity of CPS-K was compared with LPS, one of the most extensively investigated interferon inducers in experimental animals.
MATERIALS AND METHODS Animals. Male and female SMA mice weighing 20 to 25 g were used.
Preparation of CPS-K and fractionation of acidic and neutral CPS-K. CPS-K was prepared from the culture fluid of K. pneumoniae type 1, Kasuya strain, according to the procedures described by Batshon et al. (1) . CPS-K is found to be fractionated into two components by the addition of cetylpyridinium chloride, acidic CPS-K (the type-specific capsular antigen), and neutral CPS-K (5, 6, 24) . The fractionation was performed as described previously (19) . Unless otherwise stated, CPS-K isolated from the Kasuya strain and its acidic and neutral fractions were used. In addition, preparations of neutral CPS-K isolated from K. pneumoniae type 1 (Iwate strain), type 8 (NIAH-8 strain), type 23 (MH-1 strain), type 46 (MH-2 strain), and strain KP-45 (type unidentified) were used. These materials were dissolved in produce neutral CPS-K, which is antigenically identical to that derived from the Kasuya strain (19) . Antiserum to neutral CPS-K from the MH-2 strain was produced by injecting 5 mg of this substance emulsified in complete Freund adjuvant into the footpads of rabbits. The rabbits were bled 30 days after injection. One-half volume of antiserum was added into a solution (10 ml) of neutral CPS-K dissolved in phosphate-buffered saline to a concentration of about 1 mg/ml. The mixture was incubated at 37 C for 30 min, and the sediment was separated by centrifugation at 1,000 x g for 10 min. The supernatant was mixed with 1 ml of antiserum, and the mixture was incubated at 37 C for 30 min and then centrifuged. These procedures were repeated until no further precipitate appeared. The sediments obtained by each centrifugation were collected and washed twice with phosphate-buffered saline. To recover the polysaccharide, a suspension of the sediments in water and the supernatant were treated with an equal volume of 90% hot (68 C) phenol (15 Preparation of bacterial LPS. LPS of Salmonella enteritidis strain NUB 1 was prepared by a phenolwater procedure (24) . LPS was further purified by ultracentrifugation at 100,000 x g for 2 h. The sediment after ultracentrifugation was washed with 95% ethanol and dried in vacuo. The preparation of LPS was dissolved in phosphate-buffered saline and used for experiments.
Induction of interferon in mice. Material to be tested was injected intravenously into mice. At various times after injection, mice were lightly anesthetized with ether, and blood was obtained aseptically by cutting the axillary artery. Serum of pooled blood from a group of three to five mice was used for interferon assays.
Interferon assays. Interferon assays were conducted by the cytopathic effect-inhibition method using a continuous line of mouse L cells and vesicular stomatitis virus as the challenge virus. L cells were grown to confluence at 37 C for 3 days in test tubes using Eagle minimal essential medium with 5% calf serum as a growth medium. Interferon samples were diluted in 10-fold steps in a maintenance medium (minimal essential medium with 2% calf serum), and a 1-ml amount of each dilution was added to groups of two tubes. The tubes were incubated at 37 C overnight and then drained and challenged with 100 mean tissue culture infecting doses of vesicular stomatitis virus. After incubation at 37 C for 2 days, the cytopathic effect in each tube was examined. Interferon titer was expressed as the final dilution of interferon samples at which the cytopathic effect score was less than one-half of that in the control tubes (9) . A standard reference interferon sample was included in each assay. Interferon titers described in this report are adjusted to units of the reference mouse interferon standard provided by the Antiviral Substances Program of the National Institute of Allergy and Infectious Diseases, Bethesda, Md.
RESULTS
Kinetics of interferon production by CPS-K and LPS in mice. The time pattern of interferon production was followed in mice injected intravenously with a single dose of 10 or 100 gg of CPS-K and LPS. Serum samples obtained at various times after injection were assayed for interferon (Fig. 1) . The time pattern of interferon production for both inducers was very similar. Interferon appeared quickly in the serum, reached a peak at 2 h after injection, and declined gradually thereafter.
Interferon production in mice inoculated with various doses of CPS-K and LPS. Groups of mice were injected intravenously with various doses of CPS-K and LPS in 10-fold steps. Serum samples obtained 2 h after injection, the time of peak interferon titers, were assayed for interferon (Table 1) . With both CPS-K and LPS, a dose-response relationship was found up to 100 lg, the maximal dose used in this experiment. The minimal effective dose of CPS-K to induce interferon production was at least 10 times smaller than that of LPS.
Comparison of the interferon-inducing activity of neutral and acidic CPS-K. To determine the active substance responsible for the interferon-inducing activity of CPS-K, serum samples obtained from groups of mice inoculated intravenously with various doses of neutral and acidic CPS-K were assayed for interferon (Table 2) . Neutral CPS-K exhibited a much stronger inducing activity than acidic CPS-K. An injection of 1 ,g of acidic CPS-K was much less effective than an injection of 0.01 ,ug of neutral CPS-K. This finding indicates that the active substance responsible for the interferon-inducing activity of CPS-K exists in the fraction of neutral CPS-K.
Comparison of the interferon-inducing activity of antibody-precipitable and unprecipitable fractions of neutral CPS-K. Fractions of neutral CPS-K separated by precipitation with antibody were tested for their interferon-inducing effect (Table 3 ). The antibodyprecipitable fraction of neutral CPS-K exhibited a strong inducing activity comparable to the original preparation of neutral CPS-K, whereas the inducing activity of the unprecipi- moniae, which was used for fractionation of the antibody-precipitable fraction of neutral CPS-K, developed only one definite precipitin line against neutral CPS-K from the Kasuya strain in agar gel. The results of this experiment indicate that this antigenic substance is the active substance responsible for the interferoninducing effect of CPS-K.
Interferon-inducing activity of neutral CPS-K isolated from various strains of K. pneumoniae. As reported previously (19) , the active substance responsible for the strong adjuvant activity of CPS-K is also neutral CPS-K. However, this activity is restricted to the preparations of neutral CPS-K having an identical antigenicity to that derived from the Kasuya strain. To determine the correlation between the adjuvant and interferon-inducing activities of neutral CPS-K, several preparations of neutral CPS-K isolated from various strains of K. pneumoniae were studied for their interferoninducing capacity ( other strains, which showed no obvious adjuvant activity, exhibited a significant interferoninducing capacity comparable to neutral CPS-K from the Kasuya strain.
Comparison of the ability of neutral CPS-K and LPS to induce tolerance to interferon production by CPS-K and LPS (homologous and heterologous tolerance). It has been well established that a prior administration of a certain inducer into animals induces the tolerance or hyporeactivity to a subsequent injection of the same or another inducer (12, 13) . It has been reported that, among various inducers, LPS produces the tolerant state most efficiently (12, 13) . Neutral CPS-K and LPS were compared for their capacity to induce the tolerance to re-induction of interferon by CPS-K and LPS. Groups of mice were injected intravenously with various doses of neutral CPS-K or LPS. These mice were again injected intravenously with 1 jig of CPS-K or 10 gg of LPS 24 h later. The control group of mice was primarily injected with phosphate-buffered saline in place of the inducers, and 24 h later they were secondarily injected with CPS-K or LPS. Serum samples obtained 2 h after the second injection were assayed for interferon ( Effect of acidic CPS-K on interferon response to a subsequent injection of CPS-K and LPS. Acidic CPS-K, whose interferoninducing activity was shown to be very weak in comparison with neutral CPS-K (Table 2) , was studied for its capacity to induce the tolerance to re-induction of interferon by CPS-K or LPS ( Table 6 ). The experimental procedures were the same as in the experiment just described. The capacity of acidic CPS-K to produce the tolerance was very similar to that of neutral CPS-K; namely, tolerance to both CPS-K and LPS was induced by a prior injection of as little as 0.1 Mg of acidic CPS-K. This dose of acidic CPS-K induced no detectable interferon production (Table 2) . From the results of this experiment, as well as those of the experiment Table 5 .
described in the preceding section (Table 5) , it can be concluded that there is no direct parallelism in the abilities of interferon in.ducers to induce interferon production and to induce tolerance to a subsequent interferon response. DISCUSSION CPS-K has been shown to be fractionated into two components: acidic CPS-K (the type-specific capsular antigen) and neutral CPS-K (5, 6, 19, 24) . The results of this study indicate that the active substance responsible for the interferon-inducing effect of CPS-K is the neutral CPS-K antigen. It has been confirmed that this neutral CPS-K antigen is antigenically distinct from the 0 antigen and from the type-specific acidic CPS-K antigen (19) . These findings and the more potent interferon-inducing activity on a weight basis of CPS-K than LPS exclude the possibility that LPS contaminating in the preparations of CPS-K and neutral CPS-K may contribute substantially. The preparation of acidic CPS-K exhibited a very weak interferoninducing effect. As described previously (19) , the preparation of acidic CPS-K used contains small amounts of neutral CPS-K as a contaminant. It seems to be, therefore, that its weak effect is due to neutral CPS-K contaminating in the preparation of acidic CPS-K. Neutral CPS-K has been found also to be the active substance for the strong adjuvant activity of CPS-K (19, 20) . In addition, it has been foiind that the strong adjuvant activity of neutral CPS-K is restricted to the particular neutral CPS-K which is antigenically identical with neutral CPS-K derived from the Kasuya strain (19) . Study with the preparations of neutral CPS-K isolated from various strains has revealed that the interferon-inducing activity of neutral CPS-K does not necessarily correlate with the adjuvant activity (Table 4) .
A variety of polysaccharides have been found to be active in inducing interferon production in vivo (3, 4, 17, 26, 27) . On the basis of the effective doses, CPS-K may be a more potent interferon inducer than the other polysaccharide inducers reported so far. Among the polysaccharides, mannan from Candida albicans studied by Boreck' et al. (3) was the first to be shown as an interferon inducer. The C. albicans mannan was thought not to contain phosphate groups. It was later shown, however, that mannan from yeast failed to show the interferoninducing activity in its natural form, but it became active when it was chemically phosphorylated (27) . Phosphomannans from Hansenula were found to induce interferon in rabbits (26) . It was also found that several synthesized or isolated anionic polysaccharides were active in inducing interferon production in animals (4, 17, 27) . In this connection, our conclusion that the active substance for the interferon-inducing effect of CPS-K is not acidic CPS-K but neutral CPS-K may contrast with the polyanionic nature of most interferon inducers. The purified preparation of neutral CPS-K from the Kasuya strain is composed mainly of carbohydrates, and it contains small amounts (2.3%) of proteins and lesser amounts of lipids (19) . This is in contrast to the chemical composition of cell wall LPS (15) and the free type of endotoxin (lipoglycopeptide) (2, 16, 25) of gram-negative bacilli. It has been suggested that the component of endotoxin essential for its interferon-inducing action is the lipid (7, 8) . At present, it is not yet known if the lipid in the neutral CPS-K antigen is essential for the interferon-inducing activity of this substance, although its amount is minute.
Early reports that CPS-K derived from K. pneumoniae type 2 inhibited the multiplication of the pneumonitis virus of mice (11, 14) and mumps virus (10) have not yet been reconfirmed by us using our preparations of CPS-K. Its antiviral effect on the pneumonitis virus of mice was reported to be marked; this substance was capable of protecting mice against death from viral pneumonia when administered intranasally after definite pneumonia had developed (11) . In this study, however, whether interferon can be produced in the pulmonary tissues by intranasal inoculation of CPS-K has VOL 12, 1975 Homologous and heterologous tolerance to re-induction of interferon is produced by a prior administration of' either LPS, neutral CPS-K, or acidic CPS-K. No simple correlation exists between the inducing and tolerogenic capabilities of these substances. This f'inding does not conflict with the results reported previously (12, 13) . It should be emphasized that acidic CPS-K without a significant inducing capacity shows a marked tolerogenic capacity comparable to neutral CPS-K with a potent inducing capacity. It is unlikely, therefore, that the induction of tolerance to interferon response depends directly upon the production of' interferon.
